Left Main Coronary Artery Dissection Complicating Diagnostic Coronary Angiography Layth A. Mimish MBChB, FRCPC, FACC Medical Director The Cardiovascular.

Slides:



Advertisements
Similar presentations
MAIN-COMPARE Study – Disclosure Information
Advertisements

A Prospective, Randomized Comparison of Paclitaxel-eluting TAXUS Stents vs. Bare Metal Stents During Primary Angioplasty in Acute Myocardial Infarction.
2013 ACCF/AHA/SCAI Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures A Report of the American College of Cardiology.
Call for CASES Motaz AbuSamra Krzysztof Milewski CCU, Upper-Silesian Center of Cardiology, Silesian Medical School, Katowice, Poland Head of Department:
MAIN-COMPARE Study Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease.
IVUS Use during Left Main PCI improve Immediate and Long Term Outcome Where is the Evidence? E Murat Tuzcu, MD, FACC Professor of Medicine Vice Chairman.
CABG VS Multi Vessel PCI Hasanat Sharif MD FRCS Chief of Cardiorthoracic Surgery Aga Khan University Hospital.
BIFURCATION LESIONS Dr. Tahsin.N
Professor Abdus Samad MD FACC Karachi Institute of Heart Diseases Karachi, Pakistan May 1, 2010.
Coronary Revascularisation in Patients With Diabetes Mellitus Dr Rod Stables The Cardiothoracic Centre Liverpool UK.
The Radial Approach to Percutaneous Coronary Intervention Is Associated With a Lower Risk for Complications Regardless of Radial Procedure Volume: A Report.
ARTS I & II Keith D Dawkins Southampton University Hospital.
Complications of HSRA Layth A. Mimish Consultant Cardiologist Cardiovascular Consultants Group Jeddah, Saudi Arabia.
Directional Coronary Atherectomy KFSH & RC Experience Layth A. Mimish, J. Buraiki, M. E. Fawzy, B. Dunn, M. Bakhshi, B. Dajani.
CABG GUIDELINES SANJAY DRAVID, M.D.. INTRODUCTION ACC/AHA GUIDELINE UPDATE FOR CORONARY ARTERY BYPASS GRAFT SURGERY (JACC 2004; 44: AND CIRCULATION.
29th ANNUAL SCIENTIFIC SESSIONS – SCA&I
STEMI Due to Stent Thrombosis: An Enlarging Subgroup of High Risk Patients Bruce Brodie, Adam Bensimhon, Nathan Fleishman, Charles Hansen, Mike Cooper,
Unrestricted Use of Drug-Eluting Stents Compared with Bare-Metal Stents in Routine Clinical Practice: Findings From the National Heart, Lung, and Blood.
SCAAR UCR SWEDEN 2007 Stefan James, Jörg Carlsson, Johan Lindbäck, Tage Nilsson, Ulf Stenestrand, Lars Wallentin and Bo Lagerqvist for the SCAAR study.
Tips and Pitfalls in Measurement of FFR during Bifurcation Stenting Nanjing first hospital Nanjing cardiovascular hospital Yefei Chenshaoliang Zhangjunjie.
Coronary Artery Disease in Diabetic Patients, Different from Non-diabetics?
ICE Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,
1 SIROLIMUS-ELUTING STENTS FOR IN-STENT RESTENOSIS TREATMENT IN 278 UNSELECTED PATIENTS: INSIGHTS ON LONG-TERM OUTCOMES FROM A LARGE TWO-CENTER REGISTRY.
Arterial Revascularization Therapies Part II: a non- randomized comparison of contemporary PCI and coronary artery bypass grafting (CABG) in patients with.
Two-Year Clinical Outcomes Yan Li MD., PhD. On behalf of FIREMAN Investigators Associated Professor of Department of Cardiology of Xijing Hospital Fourth.
Disclosures The presenter has no financial involvement with the product or competing products being discussed. The presenter received travel and lodging.
Long Term Clinical Outcomes Following Drug-Eluting and Bare Metal Stenting in Massachusetts Laura Mauri, MD, MSc; Treacy Silverstein, B.Sc.; Ann Lovett,
Does Openness Improve Outcome ? The North-West Quality Improvement Program Dr R H Stables Cardiothoracic Centre Liverpool.
Revascularizaton of Ischemic DCM Percutaneous Revascularization and Hemodynamic Support Matthew R. Wolff, M.D. University of Wisconsin Disclosures: Cordis.
FRONTIER Registry The Guidant MULTI-LINK FRONTIER ™ Coronary Stent System for the Treatment of Pts with Native De Novo or Restenotic Bifurcation Coronary.
ΕΚΕ Hellenic PCI Registry ( ) Περιεχόμενο και αναγκαιότητα διατήρησης Registry Αγγειοπλαστικής Georgios.
Left Main Stem Intervention Trials & Registries Keith D. Dawkins MD FRCP FACC Southampton University Hospital UK.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
Transradial Approach [LEft vs right] aNd procedural Times during percutaneous coronary procedures: TALENT study ALESSANDRO SCIAHBASI, MD UO Cardiologia,
6/9/2008 Comparative effectiveness reviews: methodological observations David B. Matchar, MD Professor of Medicine and Director, Center for Clinical Health.
Direct Stenting is Better (Debate Session) 동아의대 김 무 현.
Balloon-pump assisted Coronary Intervention Study BCIS-1 Simon Redwood Divaka Perera, Rod Stables, Martyn Thomas.
Multivessel Coronary Artery Disease
Samuel Thomas Rayburn, III MD Cardiovascular Surgeon Jack Stephens Heart Institute April 25, 2015.
Columbia University Medical Center Cardiovascular Research Foundation New York City, NY Akiko Maehara, MD Use of IVUS Reduces Stent Thrombosis and Myocardial.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
J Am Coll Cardiol 2008;51:538–45 Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical Revascularization Pawel E. Buszman,
Columbia / CRF DES vs. BMS Meta-Analysis Kirtane et al, Circ 2009;119:
S Ten Tse and Sensibility!
Novel Trial Design Focus - Left Main and “All Comers” DES Studies: All-Comers Studies. Interventional View Jeffrey J. Popma, MD Director, Innovations in.
TAVR Medtronic CoreValve® Subclavian Approach Clinical Data
Shengshou Hu M.D. National Center for Cardiovascular Disease,China
Clinical Usefulness of Post-Stenting FFR
Tarek Abou Ghazala, MD, FACC, FSCAI
CRT Washington, D.C. February 23, 2010 Tim A. Fischell, M.D. FACC
Successful CTO PCI Associated with Lower Mortality Risk
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
Transradial Intervention as Access of Choice in STEMI
The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions
Catheter-Based Treatment of Coronary Artery Disease
Adjusted odds ratio 95% CI Diagnostic angiography PCI CABG
Section 5: Intervention and drug therapy
Coronary Artery Surgery
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Risk Stratification and Interventional Cardiology: Robert L
No Financial Disclosure or Conflict of Interest
A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned  Robert E.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Ahmed A. Khattab, MD For the German Cypher Registry Investigators
Improved outcomes in coronary artery bypass grafting with beating-heart techniques  Michael Mack, MD, Donna Bachand, RN, PhD, Tea Acuff, MD, James Edgerton,
Current Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting  Michael J. Mack, MD, Syma L. Prince, RN, Morley Herbert,
Atlantic Cardiovascular Patient Outcomes Research Team
Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.
Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation: a propensity score matched analysis Maurizio Taramasso MD, PhD from.
Presentation transcript:

Left Main Coronary Artery Dissection Complicating Diagnostic Coronary Angiography Layth A. Mimish MBChB, FRCPC, FACC Medical Director The Cardiovascular Consultant Clinic Jeddah, KSA

I have no conflict of interest pertaining to this presentation

Left Main Coronary Dissection Definition and Classification Incidence Etiology Management Conservative CABGS Stenting

NHLBI Classification

Left Main Coronary Dissection Spontaneous Extension from Aortic Dissection Complication of Diagnostic Coronary Angiography or Coronary Interventional procedure

Iatrogenic Left Main Coronary Dissection Calcification of Lt. Main Stem Anatomical distortion in aortic root or origin of Lt main that makes selective intubation difficult The angle formed by the tip of the catheter and the intima of the vessel The depth with which the artery is cannulated Forceful injection with dampened pressure Femoral Vs radial approach Diagnostic Vs PCI

Left Main Coronary Dissection Sone’s initial series 4200 diagnostic procedures, 1 reported dissection Massachusetts General Hospital Pts, Lt. main dissection in 1 Dennis, W., William O’Neil, Cath C V Intervention 2000, data review 43,143 diagnostic procedures and PCI (0.02%) Carter AJC cases, incidence 0.02 for diagnostic angiography, and 0.07% for PCI Under-reported, with severity varying from type A to severe aortic root dissection

Conservative Treatment

CABG Vs Medical Therapy

ACC / AHA Guidelines

Clinical Outcomes with CABG in Lt. Main Disease 18 Centers Jan 2001-June ,494 Consecutive CABG with no exclusion 1,394 Lt main (24.1%) Operative mortality 4.1% (All other CABG 2.3%) CVA 1.3% Katz, Mack, Simon

OPCAB in LMCA Disease Off PumpOn Pump n 2731,163 Predicted Mortality 4.1%3.6% Observed Mortality 2.6%4.5% Risk Adjusted Mortality 1.9%3.8% Dewey,et al, Ann Thorac Surg 2001

Motality for CABG in Lt Main NYS Database

Stent Vs Conventional Rx for Abrupt Closure or Symptomatic Dissection

French Lt Main Registry May 2001-June 2002 (11 French Centers)

French Lt Main Registry 1 Yr Outcome

French Lt Main Registry 1 Month &1 Yr Outcome

IVUS Optimization for Stent Deployment

DES Vs BMS in Milan 6 Month Clinical & Angiographic F/Up

DES in Lt Main Disease RESEARCH & T-SEARCH Registry April 16, 2002-Dec 31, 2003 > 50% Lt min Consensus agreement with CV surgeon with patient and referring MD 95 Consecutive Pts, with 1 DES (SES 52, PES 43) Comparison group 86 Consecutive pts who got BMS for Lt main immediately before DES availability Median F/UP 503 days ( )

DES in Lt Main Disease RESEARCH & T-SEARCH Registry

LMCA Intervention in AMC

In Hospital Outcome

Overall Restenosis rate 7.9%

6 Months Clinical Outcome

MACE Free Survival at 1 Year

Coclusion Rapid & thorough assessment CV Surgeon involved Haemodynamic support DES Vs emergency CABGS IVUS